
News|Articles|February 3, 2026
From Decline to Growth: How One Brand Expanded Access in Late Lifecycle
Author(s)CoverMyMeds
This case study leverages IQVIA data and analytics to explore how one pharmaceutical brand navigated mature lifecycle stages in a competitive class, implementing seamless prior auth strategies with CoverMyMeds where a 22 percentage point claim approval rate lift was observed, on average, helping mitigate decreasing access.
Trending on PharmExec
1
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
2
How Regulatory Stringency, Demand Shocks, and Repurposing Reshape Biopharma Strategy in 2026
3
Traditional Healthcare Has a Retention Problem It Refuses to Diagnose
4
Novartis to Acquire Myricx Bio for $1.1 Billion
5